A Case of Vogt-Koyanagi-Harada Disease Associated With Polycystic Ovary Syndrome by Kaya, Mehmet Kaan et al.
Case Report J Clin Med Res  •  2011;3(2):93-95
ress Elmer 
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press™   |   www.jocmr.org
A Case of Vogt-Koyanagi-Harada Disease Associated With 
Polycystic Ovary Syndrome
Mehmet Kaan Kayaa, c, Burak Turguta, Tamer Demira, Ulku Celikera, Bilgin Guratesb
Abstract
We report a female patient diagnosed as Vogt-Koyanagi-Harada 
(VKH) and polycystic ovary syndrome (PCOS). She has diagnosed 
as VKH with diminished vision, bilateral serous retinal detachment, 
the signs of fundus ﬂ  uorescein angiography and the ﬁ  ndings of op-
tical coherence tomography. The patient was referred to the gyne-
cology clinic for her complaints as weight gain, hirsutismus and 
amenorrhea. She has also been diagnosed with PCOS. With oral 
steroid treatment, visual acuity has improved and the detachments 
have resolved within a month. VKH disease may be associated with 
polycystic ovary syndrome. The two conditions may have a com-
mon autoimmune pathogenesis.
Keywords:  Autoimmune pathogenesis; Polycystic ovary syn-
drome; Vogt-Koyanagi-Harada
Introduction
Vogt-Koyanagi-Harada (VKH) disease initially manifests in 
women in their third and fourth decades of life with prodro-
mal meningeal irritation symptoms, including headache, ver-
tigo, nausea, vomiting, and low-grade fever. Posterior uveitis 
with exudative retinal detachments and optic disc hyperemia 
follow the above mentioned symptoms. It is associated with 
extra ocular manifestations such as dysacousia, tinnitus and 
alopecia, vitiligo and poliosis due to the involvement of the 
auditory system and the integument system. VKH disease 
may recur, typically as an anterior uveitis, and may result in 
marked visual loss due to the posterior segment complica-
tions [1, 2].
Polycystic ovary syndrome (PCOS) is commonly diag-
nosed in young women with anovulatory infertility, oligo-
menorrhea or hyper androgenic problems such as hirsutism 
and acnes. The key underlying abnormality is insulin resis-
tance-hyperinsulinemia in the presence of normoglycemia. 
PCOS is related to hormonal dysregulation, autoimmune 
mechanisms and metabolic disturbances such as type II dia-
betes and atherosclerotic conditions [3, 4]. Here, we pres-
ent the association of VKH disease and PCOS in a young 
female. To our knowledge, this association has not been re-
ported previously in the literature.
Case Report
A 20-year-old female was applied to our outpatient clinic 
with the complaint of decreased vision in both eyes for a 
month. Her past medical and surgical histories were unre-
markable. Her family history revealed thyroid disease in her 
mother. The visual acuity in both eyes was revealed 25/60 
with normal intraocular pressure. Slit lamp exam revealed 
2+ inﬂ  ammatory cells and ﬂ  are in anterior chamber in both 
eyes. The vitreous cavity was clear, and there was no reti-
nal vascular sheathing. Fundus examination disclosed serous 
retinal detachment and retinal folds, and also optic disc ede-
ma in both eyes (Fig. 1A, B). Fundus ﬂ  uorescein angiogra-
phy (FFA) OU revealed irregular patches of ﬂ  uorescence and 
numerous hyper ﬂ  uorescent points of leakage at the level of 
the retina pigment epithelium. The leaking points gradually 
enlarged and dye accumulated in the sub retinal space. The 
late-phases FFA showed to diffuse pooling of dye in sub reti-
nal spaces and late optic disc staining in both eyes. Optical 
coherence tomography (OCT) scans showed serous macular 
detachment with several subretinal septas in the right eye 
and a giant serous macular detachment in the left eye (Fig. 
1C, D). In this case, a diagnosis of probable VKH disease 
according to Diagnostic Criteria for Vogt-Koyanagi- Harada 
[2] was made based on the ocular examination and the typi-
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cal FFA ﬁ  ndings. She was hospitalized for topical and oral 
steroid treatments (1 mg/kg/day). The patient was consulted 
by an internist for the etiology other than VKH of the exuda-
tive detachment. There was no evidence of any focal neu-
rological deﬁ  cit. The patient refused the lumbar puncture. 
A detailed dermatological and audiometric examination re-
vealed no skin or auditory abnormalities. Laboratory inves-
tigations showed a normal hemogram and normal liver and 
kidney function tests. The result of a radiographic exami-
nation of the chest was also normal. However, she was re-
ferred to the gynecology clinic for her complaints as weight 
gain, hirsutismus and amenorrhea. Glucose tolerance testing 
showed the presence of insulin resistance. Pelvic ultrasonog-
raphy revealed enlarged polycystic ovaries with bilaterally 
increased stromal thickness and more follicles over 10 per 
ovary, ranging in diameter from 4 - 9 mm. Her body mass in-
dex (BMI) was 26.5. Serum testosterone was elevated (143.8 
ng/dl, normal < 80 ng/dl). The diagnosis of PCOS was made 
by the gynecology clinic and drospirenon + ethinyl estradiol 
treatment was started. Two weeks after the initiation of oral 
steroid therapy, sub retinal ﬂ  uid accumulations in both eyes 
dramatically decreased and the retinal folds disappeared.
In the fundus examination at the end of one month of 
corticosteroid treatment, it was observed complete reattach-
ment of retina, RPE changes as hiperpigmentation and mac-
ular ﬁ  brosis in both eye and also disc pallor in the left eye 
(Fig. 2A, B). The best-corrected visual acuity was 20/20 OU; 
OCT scans showed the resolution of macular detachments 
with formation of RPE irregularities, epi macular membrane 
and sub foveal ﬁ  brosis in both eyes (Fig. 2C, D). Thus, oral 
steroid treatment was tapered gradually and ceased at the end 
of the sixth week of treatment.
 
Figure 1. Fundus photographs show serous macular detachment and retinal folds and optic disc edema in the right 
eye (A) and in the left eye (B). Optical coherence tomography scans show serous macular detachment with several 
subretinal septas in the right eye (C) and a giant serous macular detachment in the left eye (D) at the presentation.
Figure 2. Fundus photographs show complete reattachment of retina, retinal pigment epithelial changes as hyperpig-
mentation and ﬁ  brosis at the macula in the right eye (A) and complete reattachment of retina, retinal pigment epithelial 
changes as hyperpigmentation and ﬁ  brosis at the macula, and the pallor at the optic disk in the left eye (B) after the cor-
ticosteroid treatment. Optical coherence tomography scans show the resolution of macular detachment with formation of 
retinal pigment epithelial irregularities, epi macular membrane and sub foveal ﬁ  brosis in the right eye (C) and in the left 
eye (D) after the corticosteroid treatment.
                  94J Clin Med Res  •  2011;3(2):93-95    Vogt-Koyanagi-Harada Disease and Polycystic Ovary Syndrome
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press™   |   www.jocmr.org
Discussion
  
Although the exact cause of VKH disease remains unknown, 
it is thought to be a T-cell-mediated autoimmune processes 
directed against one or more antigenic components of mela-
nocytes [5]. At present, the diagnosis of VKH disease is usu-
ally made based on the clinical ﬁ  ndings of prodromal ﬁ  nd-
ings of central nerve system followed by a bilateral exudative 
posterior uveitis. Fluorescein angiography typically reveals 
multiple hyper ﬂ  uorescent spots, which coalesce over time 
and ﬁ  ll the sub retinal space. Ultrasonography shows diffuse 
thickening of the choroid [2]. Serous retinal detachment and 
intraretinal ﬂ  uid accumulation in the outer retina in VKH 
disease have been demonstrated using OCT [6]. Once the 
diagnosis of VKH disease is made, an aggressive treatment 
with high-dose oral corticosteroids, typically in the range of 
1 to 2 mg/kg/d should be started. This therapy often results 
in no visually signiﬁ  cant sequel [2]. Vogt-Koyanagi-Harada 
disease has been reported in association with diseases of 
autoimmune origin, including thyroid disease, rheumatoid 
arthritis, and autoimmune polyglandular syndrome type 1 
[1, 2]. In addition, it has reported by Yawata et al that the 
glucose intolerance is present in 55% of patients with VKH 
disease [7]. In their report, it has been postulated as the pos-
sible inﬂ  ammatory pathogenesis causing both VKH disease 
and glucose intolerance might have been related. Because 
the identiﬁ  cation of the anti-ovarian autoantibodies and the 
autoantigens in some patients with PCOS, it has been sug-
gested that an autoimmune mechanism might play a role in 
the pathogenesis of PCOS in part [8]. In addition, glucose 
intolerance or insulin resistance which is common ﬁ  nding in 
PCOS may be a key factor in the pathophysiology of PCOS 
[9]. Clinical and epidemiological studies have shown that in-
sulin resistance is associated with glucose intolerance [10]. 
Although VKH and PCOS might be coincidentally found in 
this patient, a common autoimmune pathogenesis of these 
two diseases might be taken into account because of glucose 
intolerance found in both diseases.
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